Emerging markets hold promise for pharma sales

08/24/2010 | Economic Times (India), The

Drugmaker Lupin expects sales in emerging markets to equal sales in the U.S. and Japan, combined, by 2018. The company plans to expand operations in Brazil and Mexico, where it sees opportunity in gynecology, cardiology, oral contraceptives and biotechnology markets.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT